Search Results - "Uzunalimoglu, O"

Ligand-induced expression of peroxisome proliferator-activated receptor α and activation of fatty acid oxidation enzymes in fatty liver by Akbiyik, F., Cinar, K., Demirpence, E., Ozsullu, T., Tunca, R., Haziroglu, R., Yurdaydin, C., Uzunalimoglu, O., Bozkaya, H.

“…Background  Peroxisome proliferator‐activated receptor alpha (PPARα) regulates lipid metabolism upon activation by ligands. Peroxisome proliferator‐activated…”
Get full text

254 THE ASSOCIATION OF INTESTINAL INOS EXPRESSION AND OXIDATIVE STRESS IN EXPERIMENTAL CIRRHOSIS by Mas, M.R, Savas, B, Ocal, R, Ensari, A, Comert, B, Yilmaz, S, Isik, A.T, Mas, N, Uzunalimoglu, O

Get full text

Tumour necrosis factor-alpha, interleukin-10, interferon-gamma and vitamin D receptor gene polymorphisms in patients with chronic hepatitis delta by Karatayli, S. C., Ulger, Z. E., Ergul, A. A., Keskin, O., Karatayli, E., Albayrak, R., Ozkan, M., Idilman, R., Yalcin, K., Bozkaya, H., Uzunalimoğlu, O., Yurdaydin, C., Bozdayi, A. M.

“…Summary No data exist to assess certain polymorphisms that have a potential effect on the immune response in patients with chronic hepatitis delta (CHD). The…”
Get full text

[747] TNF-ALPHA MEDIATES THE ETHANOL INDUCED PPAR-ALPHA SUPRESSION IN THE LIVER by Onder, P.O, Sengul, S, Calayoglu, R, Savas, B, Cinar, K, Akbiyik, F, Yurdaydin, C, Uzunalimoglu, O, Ataoglu, H, Bozkaya, H

Get full text

A pilot study of 2 years of interferon treatment in patients with chronic delta hepatitis by Yurdaydın, C., Bozkaya, H., Karaaslan, H., Önder, F. O., Erkan, Ö. E., Yalçın, K., Değertekin, H., Bozdayı, A. M., Uzunalimoğlu, Ö.

“…High dose interferon treatment for 1 year is the only established treatment for chronic hepatitis D, but it is associated with a high relapse rate after…”
Get full text

Treatment of chronic delta hepatitis with lamivudine vs lamivudine + interferon vs interferon by Yurdaydın, C., Bozkaya, H., Önder, F. O., Şentürk, H., Karaaslan, H., Akdoğan, M., Çetinkaya, H., Erden, E., Erkan-Esin, Ö., Yalçın, K., Bozdayı, A. M., Schinazi, R. F., Gerin, J. L., Uzunalimoğlu, Ö., Özden, A.

“…Chronic delta hepatitis is the most severe form of chronic viral hepatitis for which interferon (IFN) is the only available treatment. In 39 patients (25 were…”
Get full text

Molecular epidemiology of hepatitis B, C and D viruses in Turkish patients by BOZDAYI, A. M, ASLAN, N, BOZKAYA, H, GERLICH, W, KARAYALCIN, S, YURDAYDIN, C, UZUNALIMOZLU, Ö, BOZDAYI, G, TÜRKYILMAZ, A. R, SENGEZER, T, WEND, U, ERKAN, Ö, AYDEMIR, F, ZAKIRHODJAEV, S, ORUCOV, S

“…Different genotypes of the hepatitis viruses may influence the clinical outcome of the disease. The distribution of genotypes may vary according to…”
Get full text

Circulating IL-2, IL-10 and TNF-alpha in chronic hepatitis B: their relations to HBeAg status and the activity of liver disease by Bozkaya, H, Bozdayi, M, Türkyilmaz, R, Sarioglu, M, Cetinkaya, H, Cinar, K, Köse, K, Yurdaydin, C, Uzunalimoglu, O

“…Preferential production of immunoregulatory cytokines may play an important role in the pathogenesis of chronic hepatitis B. We aimed to determine the serum…”
Get more information

Successful medical treatment of an epithelioid hemangioendothelioma of liver by Idilman, R, Dokmeci, A, Beyler, A R, Bastemir, M, Ormeci, N, Aras, N, Ekinci, C, Uzunalimoglu, O, De Maria, N, Van Thiel, D H

“…Hepatic epithelioid hemangioendothelioma (HEH) is a rare vascular tumor of the liver of unknown etiology. Although HEH is usually characterized by a low grade…”
Get more information

Human MLH1 deficiency predisposes to hematological malignancy and neurofibromatosis type 1 by RICCIARDONE, M. D, ÖZCELIK, T, ÖZTÜRK, M, CEVHER, B, ÖZDAG, H, TUNCER, M, GÜRGEY, A, UZUNALIMOGLU, Ö, CETINKAYA, H, TANYELI, A, ERKEN, E

“…Heterozygous germ-line mutations in the DNA mismatch repair genes lead to hereditary nonpolyposis colorectal cancer. The disease susceptibility of individuals…”
Get full text

Lamivudine vs lamivudine and interferon combination treatment of HBeAg(−) chronic hepatitis B by Yurdaydin, C., Bozkaya, H., Çetinkaya, H., Şahin, T., Karaoğuz, D., Törüner, M., Erkan, Ö., Heper, A. O., Erden, E., Bozdayi, A. M., Uzunalimoğlu, Ö.

“…To determine whether combination treatment of HBeAg(−) chronic hepatitis B is beneficial we studied 78 patients with HBeAg(−), HBV DNA‐positive chronic…”
Get full text

YSDD: a novel mutation in HBV DNA polymerase confers clinical resistance to lamivudine by Bozdayi̇, A. M., Uzunalimoğlu, Ö., Türkyi̇lmaz, A. R., Aslan, N., Sezgin, O., Sahin, T., Bozdayi̇, G., Çi̇nar, K., Pai, S. B., Pai, R., Bozkaya, H., Karayalçi̇n, S., Yurdaydi̇n, C., Schinazi, R. F.

“…The emergence of drug‐resistant virus in hepatitis B virus (HBV) patients treated with lamivudine is well documented. In this study, we determined the…”
Get full text

Zinc plasma levels after oral zinc tolerance test in nonalcoholic cirrhosis by KARAYALCIN, S, ARCASOY, A, UZUNALIMOGLU, O

“…Zinc absorption was examined in 25 nonalcoholic cirrhotic patients using the oral zinc tolerance test and comparing results to a healthy control group. With…”
Get full text

Serum cytotoxin and oxidant stress markers in N-acetylcysteine treated thioacetamide hepatotoxicity of rats by Akbay, A, Cinar, K, Uzunalimoğlu, O, Eranil, S, Yurdaydin, C, Bozkaya, H, Bozdayi, M

“…N-acetylcysteine (NAC) is a glutathione precursor used to treat several clinical conditions where intracellular oxidant-antioxidant balance is disturbed, among…”
Get more information

Risk factors for hepatocellular carcinoma in Turkey by UZUNALIMOGLU, Ozden, YURDAYDIN, Cihan, TÖZÜN, Nurdan, DEGERTEKIN, Halil, ÖKTEN, Atilla, CETINKAYA, Hülya, BOZKAYA, Hakan, SAHIN, Tülin, COLAKOGLU, Salih, TANKURT, Ethem, SARIOGLU, Mustafa, OZENIRLER, Seren, AKKIZ, Hikmet

“…The contribution of hepatitis B, hepatitis C, and excess alcohol intake to the development of hepatocellular carcinoma in Turkey was assessed. The study was…”
Get full text

Famciclovir treatment of chronic delta hepatitis by Yurdaydin, Cihan, Bozkaya, Hakan, Gürel, Selım, Tillmann, Hans L, Aslan, Nuray, Okçu-Heper, A, Erden, Esra, Yalçin, Kendal, Iliman, Nevzat, Uzunalımoǧlu, Özden, Manns, Michael P, Bozdayi, A.Mithat

“…Background/Aims: Interferon is the only established therapy for chronic delta hepatitis and alternative treatment options are an urgent need. Since successful…”
Get full text

Thrombophilic gene mutations in cirrhotic patients with portal vein thrombosis by Erkan, Ozlem, Bozdayi, Abdurrahman M, Disibeyaz, Selcuk, Oguz, Dilek, Ozcan, Muhit, Bahar, Kadir, Karayalcin, Selim, Ozden, Ali, Bozkaya, Hakan, Yurdaydin, Cihan, Uzunalimoglu, Ozden

“…OBJECTIVEThrombophilic gene mutations have been reported to be associated with the formation of portal vein thrombosis (PVT). This study aimed to investigate…”
Get full text

Dilation therapy of upper esophageal webs in two cases of Plummer-Vinson syndrome by Beyler, A R, Yurdaydin, C, Bahar, K, Gören, A, Soykan, I, Uzunalimoğlu, O

Get more information

Nucleotide divergences in the core promoter and precore region of genotype D hepatitis B virus in patients with persistently elevated or normal ALT levels by Bozdayı, A.Mithat, Bozkaya, Hakan, Repat Türkyılmaz, Ahmet, Sarýodlu, Mustafa, Çetinkaya, Hülya, Karayalçın, Selim, Yurdaydın, Cihan, Uzunalimoğlu, Özden

“…Background: Mutation in the hepatitis B virus precore codon 28, creating a translational stop codon and double 1762–1764 T/A mutations in the core promoter…”
Get full text

Prevalence of hepatitis-G virus and hepatitis-C virus infection in patients with non-Hodgkin's lymphoma by ARICAN, A, SENGEZER, T, BOZDAYI, M, BOZKAYA, H, ÜCGÜL, E, DINCOL, D, UZUNALIMOGLU, O

“…Several studies have reported that hepatitis-C virus may have a role in the development of non- Hodgkin's lymphoma. Hepatitis-G virus has hepatitis-C virus…”
Get full text